J C Parker Selected Research

J C Parker Research Topics

2	Body Weight (Weight, Body) 10/2006 - 09/2002
2	Carcinogenesis 06/2001 - 05/2000
1	Systemic Scleroderma (Systemic Sclerosis) 07/2008
1	Insulin Resistance 10/2006
1	Pulmonary Edema 12/2004
1	Type 2 Diabetes Mellitus (MODY) 09/2002
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2002
1	Necrosis 06/2001
1	Atrophy 04/2001
1	Edema (Dropsy) 04/2001
1	Ventilator-Induced Lung Injury 12/2000
1	Hyperglycemia 12/2000
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2000
1	Glioma (Gliomas) 03/2000
1	Glioblastoma (Glioblastoma Multiforme) 03/2000
1	Depressive Disorder (Melancholia) 02/2000
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2000

2	Glucose (Dextrose)FDA LinkGeneric 09/2002 - 12/2000
1	AntibodiesIBA 07/2008
1	RNA Polymerase IIIIBA 07/2008
1	Peptides (Polypeptides)IBA 10/2006
1	Insulin (Novolin)FDA Link 10/2006
1	gastric inhibitory polypeptide (3-42)IBA 10/2006
1	CytokinesIBA 12/2004
1	Interleukin-6 (Interleukin 6)IBA 12/2004
1	AlbuminsIBA 12/2004
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2002
1	Biological ProductsIBA 09/2002
1	Contrast MediaIBA 06/2002
1	alpha 2u globulinIBA 06/2001
1	Complement Receptors (Complement Receptor)IBA 04/2001
1	cobra venom factorIBA 04/2001
1	Complement Inactivating AgentsIBA 04/2001
1	Glucagon Receptors (Glucagon Receptor)IBA 12/2000
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 12/2000
1	Myosin-Light-Chain KinaseIBA 12/2000
1	CalciumIBA 05/2000
1	Proteins (Proteins, Gene)FDA Link 05/2000
1	Trichloroethylene (Trichloroethene)IBA 05/2000
1	lysophosphatidic acidIBA 03/2000
1	Myosin Type IIIBA 03/2000
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 03/2000
1	Phospholipids (Phosphatides)FDA LinkGeneric 03/2000
1	Antidepressive Agents (Antidepressants)IBA 02/2000
1	Pharmaceutical PreparationsIBA 01/2000
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2000
1	ProlactinIBA 01/2000

1	Therapeutics 09/2002